Matthias Guckenberger
#137,416
Most Influential Person Now
Researcher
Matthias Guckenberger's AcademicInfluence.com Rankings
Download Badge
Physics
Why Is Matthias Guckenberger Influential?
(Suggest an Edit or Addition)Matthias Guckenberger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. (2020) (974)
- Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. (2020) (391)
- Stereotactic radiotherapy of primary liver cancer and hepatic metastases (2006) (270)
- Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? (2009) (224)
- Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. (2020) (213)
- Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. (2012) (210)
- ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams (2019) (205)
- ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. (2017) (196)
- MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (191)
- A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy (2012) (190)
- Investigation of the usability of conebeam CT data sets for dose calculation (2008) (183)
- Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. (2009) (181)
- Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. (2006) (181)
- kV Cone-Beam CT-Based IGRT (2011) (178)
- Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) (165)
- Radiotherapy in adrenocortical carcinoma (2009) (164)
- Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis (2013) (158)
- NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma. (2018) (155)
- Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. (2015) (151)
- Definition of stereotactic body radiotherapy (2013) (150)
- Four-dimensional treatment planning for stereotactic body radiotherapy. (2007) (149)
- Definition of synchronous oligo-metastatic non-small cell lung cancer - a consensus report. (2019) (148)
- Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review. (2017) (148)
- European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. (2017) (147)
- Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. (2010) (144)
- Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. (2007) (144)
- Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020) (143)
- Precision of Image-Guided Radiotherapy (IGRT) in Six Degrees of Freedom and Limitations in Clinical Practice (2007) (139)
- Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. (2007) (133)
- Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table. (2007) (133)
- Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis (2014) (132)
- Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma. (2017) (131)
- Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. (2009) (129)
- Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. (2014) (129)
- Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors (2006) (129)
- Influence of inter-observer delineation variability on radiomics stability in different tumor sites (2018) (126)
- Is a single respiratory correlated 4D-CT study sufficient for evaluation of breathing motion? (2007) (125)
- Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy". (2016) (123)
- Stereotactic radiosurgery for treatment of brain metastases (2014) (121)
- Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer. (2011) (117)
- The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases (2018) (107)
- Transcriptome Analysis of Neisseria meningitidis during Infection (2003) (104)
- Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. (2013) (103)
- Evaluation of an automated knowledge based treatment planning system for head and neck (2015) (103)
- Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial. (2019) (102)
- Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. (2017) (101)
- Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. (2016) (99)
- Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? (2012) (97)
- Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors (2012) (96)
- Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma (2017) (95)
- Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. (2015) (95)
- Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. (2020) (95)
- Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study (2018) (91)
- LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. (2015) (91)
- Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. (2020) (90)
- Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery (2012) (87)
- Modern therapeutic approaches for the treatment of malignant liver tumours (2020) (86)
- Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. (2016) (84)
- A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy (2012) (83)
- Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. (2008) (82)
- Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. (2015) (82)
- Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery (2020) (81)
- A dosimetric comparison of real-time adaptive and non-adaptive radiotherapy: A multi-institutional study encompassing robotic, gimbaled, multileaf collimator and couch tracking (2016) (80)
- Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models. (2017) (78)
- Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy. (2010) (75)
- Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control. (2017) (74)
- Reliability of the bony anatomy in image-guided stereotactic radiotherapy of brain metastases. (2007) (73)
- Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. (2010) (72)
- Nonrigid Patient Setup Errors in the Head-and-Neck Region (2007) (71)
- Stereotactic body radiation therapy in the re-irradiation situation – a review (2013) (71)
- Intensity-Modulated Radiotherapy (IMRT) of Localized Prostate Cancer (2007) (70)
- Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. (2011) (70)
- Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): system description and prototype testing. (2008) (69)
- Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. (2017) (69)
- Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT). (2007) (68)
- Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer (2010) (66)
- Stereotactic body radiotherapy for liver tumors (2014) (65)
- Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer (2008) (62)
- Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy (2017) (61)
- Intensity-modulated radiotherapy for lung cancer: current status and future developments. (2014) (60)
- Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. (2016) (60)
- Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement (2020) (57)
- Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. (2014) (54)
- Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group. (2012) (53)
- Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): System description and prototype testing. (2008) (53)
- The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases (2019) (52)
- Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives. (2007) (52)
- Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) (52)
- Transcriptome-based antigen identification for Neisseria meningitidis. (2003) (51)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (50)
- Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. (2012) (50)
- Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition (2020) (49)
- PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial (2020) (49)
- Tracking moving objects with megavoltage portal imaging: a feasibility study. (2006) (49)
- Late small bowel toxicity after adjuvant treatment for rectal cancer (2006) (48)
- Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease. (2017) (47)
- Stability of radiomic features in CT perfusion maps (2016) (47)
- Analysis of the Heat Shock Response of Neisseria meningitidis with cDNA- and Oligonucleotide-Based DNA Microarrays (2002) (46)
- Clinical practice of image-guided spine radiosurgery - results from an international research consortium (2011) (45)
- Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction (2018) (45)
- SBRT for oligoprogressive oncogene addicted NSCLC. (2017) (44)
- Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa). (2016) (44)
- Spinal metastases: Is stereotactic body radiation therapy supported by evidences? (2016) (44)
- Influence of retrospective sorting on image quality in respiratory correlated computed tomography. (2007) (43)
- Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease. (2017) (42)
- Hypofractionated radiotherapy for prostate cancer (2014) (42)
- Effect of Breathing Motion in Radiotherapy of Breast Cancer (2009) (42)
- Image guidance in radiation therapy for better cure of cancer (2020) (42)
- Progression-free and overall survival for concurrent nivolumab with standard concurrent chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: Results from the European Thoracic Oncology Platform NICOLAS phase II trial (ETOP 6-14). (2020) (42)
- First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia. (2020) (42)
- Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy (2018) (42)
- ITV, mid-ventilation, gating or couch tracking - A comparison of respiratory motion-management techniques based on 4D dose calculations. (2017) (42)
- Technology‐driven research for radiotherapy innovation (2020) (41)
- Stereotactic body radiotherapy for centrally located stage I NSCLC (2014) (41)
- CT radiomics and PET radiomics: ready for clinical implementation? (2019) (40)
- Planning benchmark study for SBRT of early stage NSCLC (2017) (40)
- Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer (2018) (40)
- Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer (2019) (39)
- Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial. (2021) (39)
- Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy". (2017) (39)
- A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept --a compromise between small safety margins and long duty cycles. (2011) (38)
- Evolution of treatment strategies for oligometastatic NSCLC patients - A systematic review of the literature. (2019) (38)
- Does Intensity Modulated Radiation Therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? (2008) (37)
- Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. (2016) (37)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (37)
- Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. (2018) (37)
- Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer. (2013) (36)
- Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer (2012) (36)
- Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (36)
- LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation (2019) (35)
- Motion compensation in radiotherapy. (2012) (35)
- Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. (2015) (33)
- Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development (2020) (32)
- Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation. (2019) (32)
- Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. (2018) (32)
- Comparison of a multileaf collimator tracking system and a robotic treatment couch tracking system for organ motion compensation during radiotherapy. (2012) (32)
- Moderately hypofractionated radiotherapy for localized prostate cancer (2013) (31)
- Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. (2019) (31)
- Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (31)
- Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer. (2018) (29)
- Feasibility and Usability Aspects of Continuous Remote Monitoring of Health Status in Palliative Cancer Patients Using Wearables (2019) (29)
- Prediction of Early Death in Patients with Early‐Stage NSCLC—Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach? (2016) (29)
- Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? (2019) (29)
- Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases. (2009) (29)
- Distinct effects of rectum delineation methods in 3D-confromal vs. IMRT treatment planning of prostate cancer (2006) (28)
- Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results (2010) (28)
- Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (28)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (28)
- Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. (2019) (28)
- Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL (2019) (28)
- Treatment plan quality during online adaptive re-planning (2020) (27)
- ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (27)
- Influence of continuous table motion on patient breathing patterns. (2010) (27)
- Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT. (2019) (27)
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
- Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments. (2016) (26)
- Mid-ventilation concept for mobile pulmonary tumors: internal tumor trajectory versus selective reconstruction of four-dimensional computed tomography frames based on external breathing motion. (2009) (26)
- Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial (2012) (26)
- Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study. (2019) (26)
- Stereotactic Radiosurgery for Multiple Brain Metastases (2019) (25)
- The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy (2017) (25)
- A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015 (2016) (24)
- Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals. (2013) (24)
- Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC) (2009) (24)
- The evolution and rise of stereotactic body radiotherapy (SBRT) for spinal metastases (2018) (24)
- Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. (2015) (24)
- Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. (2020) (24)
- Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer. (2006) (24)
- SBRT for centrally localized NSCLC – What is too central? (2016) (23)
- Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study (2018) (23)
- Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (23)
- Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer (2019) (23)
- Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate (2006) (23)
- Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? (2019) (23)
- Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity (2018) (23)
- Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas (2014) (22)
- Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial. (2018) (22)
- Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC). (2019) (22)
- Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries (2015) (22)
- Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis (2021) (21)
- Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. (2019) (21)
- Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase™ training tool. (2017) (20)
- Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150. (2009) (20)
- Dose‐intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study (2018) (20)
- Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. (2013) (20)
- Radiomic biomarkers for head and neck squamous cell carcinoma (2020) (20)
- Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy - Long-term results (2009) (20)
- Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme (2011) (20)
- Optimization of combined proton-photon treatments. (2018) (19)
- Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy. (2014) (19)
- A comparison between 2-Step IMRT and conventional IMRT planning. (2007) (19)
- Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. (2013) (19)
- Validation of dynamic treatment‐couch tracking for prostate SBRT (2017) (19)
- Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries (2019) (19)
- Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases (2014) (19)
- A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives☆ (2020) (18)
- Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer (2018) (18)
- Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases. (2016) (18)
- Predisposing and precipitating risk factors for delirium in palliative care patients (2019) (18)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (18)
- Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer (2012) (17)
- Comparison of Wedge versus Segmented Techniques in Whole Breast Irradiation (2008) (17)
- Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). (2019) (17)
- Variability in spine radiosurgery treatment planning – results of an international multi-institutional study (2012) (17)
- Interchangeability of radiomic features between [18F]‐FDG PET/CT and [18F]‐FDG PET/MR (2019) (17)
- Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database (2021) (17)
- Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. (2015) (17)
- Side-ffects 15 Years after Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925. (2021) (17)
- Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma (2020) (17)
- Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group (2017) (17)
- FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients (2020) (17)
- “HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer (2017) (17)
- ELPHA: Dynamically deformable liver phantom for real‐time motion‐adaptive radiotherapy treatments (2019) (17)
- Performance comparison of prediction filters for respiratory motion tracking in radiotherapy. (2019) (17)
- mHealth Technologies for Palliative Care Patients at the Interface of In-Patient to Outpatient Care: Protocol of Feasibility Study Aiming to Early Predict Deterioration of Patient’s Health Status (2017) (17)
- Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients. (2020) (16)
- Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer (2016) (16)
- Preserving the legacy of reirradiation: A narrative review of historical publications (2017) (16)
- Second re-irradiation: a narrative review of the available clinical data (2017) (16)
- Comparison of multi-leaf collimator tracking and treatment-couch tracking during stereotactic body radiation therapy of prostate cancer. (2017) (16)
- Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. (2022) (16)
- Recommendations regarding cardiac stereotactic body radiotherapy for treatment-refractory ventricular tachycardia. (2021) (16)
- Carbon Fiber/Polyether Ether Ketone (CF/PEEK) Implants Allow for More Effective Radiation in Long Bones (2020) (16)
- Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study (2020) (15)
- A multi-national report on methods for institutional credentialing for spine radiosurgery (2013) (15)
- Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT. (2019) (15)
- Non-parametric intravoxel incoherent motion analysis in patients with intracranial lesions: Test-retest reliability and correlation with arterial spin labeling (2016) (15)
- Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria (2018) (15)
- Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long‐Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01) (2019) (14)
- Patterns of Care in the Radiotherapy of Prostate Cancer in Northern Bavaria 1998–2000 (2007) (14)
- Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. (2019) (14)
- Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy (2008) (14)
- Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. (2018) (14)
- Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: A Synthesis of International Practice Patterns to Guide Treatment Planning. (2020) (13)
- Radiation recall dermatitis induced by sorafenib (2016) (13)
- Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations (2018) (13)
- Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study. (2019) (13)
- Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss. (2019) (13)
- Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease (2017) (13)
- Prospective randomized clinical studies involving reirradiation (2016) (13)
- Radiomics Feature Activation Maps as a New Tool for Signature Interpretability (2020) (12)
- Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation (2012) (12)
- Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"? (2013) (12)
- Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis (2021) (12)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (12)
- Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer. (2017) (12)
- Four Dimensional Target Volume Generation in Pulmonary Stereotactic Body Radiotherapy (2007) (12)
- Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy (2018) (12)
- Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis (2021) (12)
- Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types. (2021) (12)
- Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy (2020) (12)
- Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 doses. (2020) (11)
- Three-dimensional spatial modelling of the correlation between abdominal motion and lung tumour motion with breathing (2006) (11)
- Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. (2019) (11)
- Image-guided Radiotherapy Based on Kilovoltage Cone-beam Computed Tomography - A Review of Technology and Clinical Outcome (2011) (11)
- Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer (2017) (11)
- Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. (2022) (11)
- Distance to Isocenter is not associated with an increased risk for Local Failure in LINAC-based Single-Isocenter Stereotactic Radiosurgery (SRS) or Radiotherapy (SRT) for Multiple Brain Metastases. (2021) (11)
- Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next? (2015) (11)
- Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy. (2017) (11)
- Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial (2021) (11)
- A multinational pooled analysis of 434 cases of stage I non-small cell lung cancer (NSCLC) treated with volumetrically image-guided (VIGRT) stereotactic lung radiotherapy (SBRT): Results from the Elekta Collaborative Lung Research Group. (2010) (11)
- Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report (2018) (11)
- Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial (2020) (10)
- Technical know‐how in stereotactic ablative radiotherapy (SABR) (2016) (10)
- Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma – Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes (2021) (10)
- Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study (2019) (10)
- Absenteeism and presenteeism in healthcare workers due to respiratory illness (2020) (10)
- Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists (2021) (10)
- The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report. (2020) (10)
- Perfusion CT radiomics as potential prognostic biomarker in head and neck squamous cell carcinoma (2019) (10)
- SBRT in operable early stage lung cancer patients. (2014) (10)
- An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer (2021) (9)
- Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine. (2014) (9)
- Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy. (2016) (9)
- Combined proton-photon treatments - A new approach to proton therapy without a gantry. (2020) (9)
- World Congress Integrative Medicine & Health 2017: part two (2017) (9)
- Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer (2017) (9)
- Radiotherapy quality assurance of SBRT for patients with centrally located lung tumours within the multicentre phase II EORTC Lungtech trial: Benchmark case results. (2019) (9)
- Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC: Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial (2019) (9)
- Risk for surgical complications after previous stereotactic body radiotherapy of the spine (2017) (8)
- Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy. (2022) (8)
- Substantial Dose-response Relationship with Clinical Outcome for Lung Stereotactic Body Radiotherapy (SBRT) Delivered via Online Image Guidance (2010) (8)
- Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy (2020) (8)
- Dosimetric and geometric end-to-end accuracy of a magnetic resonance guided linear accelerator (2020) (8)
- Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study (2019) (8)
- A Bayesian network model of lymphatic tumor progression for personalized elective CTV definition in head and neck cancers (2019) (8)
- Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users (2021) (8)
- MA25.02 Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts (2018) (8)
- Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. (2020) (8)
- Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy (2020) (7)
- The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. (2017) (7)
- Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch. (2022) (7)
- Changes in penile bulb dose when using the Clarity transperineal ultrasound probe: A planning study. (2016) (7)
- Perspectives on oligometastasis: challenges and opportunities. (2018) (7)
- Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology (2021) (7)
- Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (7)
- Dose-intensified versus conventional dose-salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: Six-year outcomes of the SAKK 09/10 randomized phase III trial. (2021) (7)
- Studies on the role of osteopontin-1 in endometrial cancer cell lines (2013) (7)
- Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study. (2022) (7)
- Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study. (2022) (7)
- Modeling and performance evaluation of a robotic treatment couch for tumor tracking (2016) (7)
- The development of stereotactic body radiotherapy in the past decade: a global perspective. (2015) (7)
- Developing an Integrative Treatment Program for Cancer-Related Fatigue Using Stakeholder Engagement – A Qualitative Study (2017) (7)
- Radiation holidays stimulate tumor immunity (2015) (7)
- Assessment of extracranial metastatic disease in patients with brain metastases: how much effort is needed in the context of evolving survival prediction models? (2021) (7)
- Radiotherapy of the oldest old—feasibility and institutional analysis (2020) (7)
- Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy. (2007) (7)
- Single-isocenter versus multiple-isocenters for multiple lung metastases: evaluation of lung dose (2021) (6)
- Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study (2021) (6)
- Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy (2019) (6)
- Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer (2021) (6)
- LONG-TERM RESULTS OF DOSE-INTENSIFIED FRACTIONATED STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR PAINFUL SPINAL METASTASES. (2021) (6)
- Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.). (2008) (6)
- Oligoprogression: Eine innovative Indikation für die Körperstereotaxie bei metastasierten Tumorsituationen (2015) (6)
- Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. (2021) (6)
- Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancer. (2007) (6)
- Imaging-based prevalence of oligometastatic disease: A single-center cross-sectional study. (2022) (6)
- The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion. (2019) (6)
- Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis (2021) (6)
- Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis (2020) (6)
- Interobserver variability in target volume delineation of hepatocellular carcinoma (2017) (6)
- The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: results from the EORTC 22922/10925 randomised trial. (2022) (6)
- Tumor Oxygenation by Myo-Inositol Trispyrophosphate Enhances Radiation Response. (2021) (6)
- A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question? (2015) (5)
- 68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer (2021) (5)
- Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis (2022) (5)
- Underweight and weight loss are predictors of poor outcome in patients with brain metastasis (2019) (5)
- Dosimetric consequences of inter-fraction breathing-pattern variation on radiotherapy with personalized motion-assessed margins (2011) (5)
- Erratum to “Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study” [Radiother Oncol 85 (2007) 435–442] (2008) (5)
- Die deutsche S3-Leitlinie zum Nierenzellkarzinom (2017) (5)
- High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation (2021) (5)
- MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands (2021) (5)
- The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas (2021) (5)
- Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking. (2020) (5)
- Secondary attack rates from asymptomatic and symptomatic influenza virus shedders in hospitals: Results from the TransFLUas influenza transmission study (2021) (5)
- Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: A long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis. (2019) (5)
- An international Delphi consensus for pelvic Stereotactic Ablative Radiotherapy re-irradiation. (2021) (5)
- Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (5)
- On the use of a hexapod table to improve tumour targeting in radiation therapy (2007) (5)
- TRANSPERINEAL INJECTION OF HYALURONIC ACID IN ANTERIOR PERIRECTAL FAT TO DECREASE RECTAL TOXICITY FROM RADIATION DELIVERED WITH INTENSITY-MODULATED BRACHYTHERAPY OR EBRT FOR PROSTATE CANCER PATIENTS : IN REGARD TO PRADA ET AL. Authors' reply (2008) (5)
- Analysis of lymphatic metastasis and progression patterns for clinical target volume (CTV) definition in head and neck squamous cell carcinoma (HNSCC) (2019) (5)
- Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience (2021) (5)
- MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (4)
- [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist]. (2018) (4)
- Validation of high-risk CT features for detection of local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer (4)
- SBRT for Central Tumors in Early Stage NSCLC Patients (2017) (4)
- 4D-CT-based motion correction of PET images using 3D iterative deconvolution (2019) (4)
- Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study (2022) (4)
- Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. (2021) (4)
- A pattern of care analysis: Prosthetic rehabilitation of head and neck cancer patients after radiotherapy. (2020) (4)
- Systematic Review on the Association of Radiomics with Tumor Biological Endpoints (2021) (4)
- MR-guided beam gating: Residual motion, gating efficiency and dose reconstruction for stereotactic treatments of the liver and lung. (2022) (4)
- Combining deep learning and radiomics to predict HPV status in oropharyngeal squamous cell carcinoma (2018) (4)
- Monitoring Patients in Ambulatory Palliative Care: A Design for an Observational Study (2016) (4)
- What is the current status of Stereotactic body radiotherapy for stage I non-small cell lung cancer? (2011) (4)
- Long-term cancer survivors treated with multiple courses of repeat radiation therapy (2021) (4)
- [Image-guided radiation therapy]. (2012) (4)
- NTCP Modeling for Radiation Pneumonitis after SBRT for Malignant Pulmonary Lesions: Results of a Multi-institutional Analysis (2011) (4)
- Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective. (2022) (4)
- Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches (2017) (4)
- SBRT Dose and Survival in Non-Small Cell Lung Cancer: In Regard to Koshy et al. (2015) (4)
- In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO) (2021) (4)
- Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research (2021) (4)
- Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis (2020) (3)
- Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy (2022) (3)
- 125: HALT: Targeted therapy beyond progression with or without dose-intensified radiotherapy in oligoprogressive disease in oncogene addicted lung tumours (2017) (3)
- OC-0061 EORTC 22113-8113 Lungtech trial on SBRT of central lung tumors (2019) (3)
- Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study (2019) (3)
- Abstract LB-151: The novel tubulin-binding, tumor checkpoint controller BAL101553 has differential effects on tumor vascularization with IV and oral dosing and provides superior anti-tumor activity in combination with bevacizumab (2017) (3)
- Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery (2012) (3)
- Accounting for range uncertainties in the optimization of combined proton-photon treatments via stochastic optimization. (2020) (3)
- Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose (2021) (3)
- Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface (2021) (3)
- Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. (2022) (3)
- OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice (2016) (3)
- SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation. (2016) (3)
- Body motion during dynamic couch tracking with healthy volunteers (2018) (3)
- Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (3)
- 1042 : Cone-Beam CT Based Image-Guidance for Hypofractionated Radiotherapy of Intrapulmonary Lesions - Evaluation of Benefits and Limitations (2006) (3)
- Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study. (2022) (3)
- OC-0399: Dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients (2016) (3)
- Time Interval Between Staging FDG Positron Emission Tomography (PET) and Initiation of Stereotactic Lung Radiotherapy (SBRT) Impacts the Risk of Recurrence and Metastasis in Non-small Cell Lung Cancer (NSCLC) (2010) (3)
- A 2.5D convolutional neural network for HPV prediction in advanced oropharyngeal cancer (2022) (3)
- Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (3)
- Recommendations for Radiation Therapy in Oligometastatic Prostate Cancer: an ESTRO-ACROP Delphi consensus. (2022) (3)
- Stereotaktische Strahlentherapie bei Lungenkrebs im Stadium I – gibt es eine Evidenz? (2017) (3)
- Focal Radiotherapy of Brain Metastases in Combination With Immunotherapy and Targeted Drug Therapy. (2021) (3)
- Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) (3)
- Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy (2021) (3)
- Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective (2022) (3)
- Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma. (2018) (3)
- 37 – Stage I Nonsmall Cell Lung Cancer and Oligometastatic Disease (2018) (3)
- Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice (2018) (3)
- International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiotherapy for Non-Spine Bone Metastases. (2021) (3)
- [Abscopal responses of local radiotherapy combined with systemic immunotherapy in patients with metastatic solid tumors]. (2016) (3)
- Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging (2021) (3)
- Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic☆ (2020) (3)
- Stereotaktische Strahlentherapie von Metastasen (2014) (3)
- Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC (2021) (2)
- Dependency of the blood oxygen level dependent-response to hyperoxic challenges on the order of gas administration in intracranial malignancies (2019) (2)
- OC-0445: Patterns of care and outcome analysis of SBRT for liver metastases - a DEGRO database initiative (2016) (2)
- Stereotactic body radiotherapy of adrenal metastases—A dose‐finding study (2022) (2)
- Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors (2012) (2)
- Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease. (2019) (2)
- [Evidence for the use of modern irradiation techniques for non-small cell lung cancer: unnecessary, inadequate, insufficient or too late?]. (2012) (2)
- EP-2197: Dose normalization in lung SBRT based on ICRU 91 and comparison to alterative normalization methods (2018) (2)
- Correction to: Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (2)
- Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model (2022) (2)
- Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life (2022) (2)
- A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction—A Technical Feasibility and Stability Study (2022) (2)
- [Stereotactic body radiotherapy for malignant nodules in the lung]. (2013) (2)
- Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer. (2022) (2)
- First two MRI guided stereotactic body radiation therapy of recurrent sustained ventricular tachycardia (2020) (2)
- A feasibility trial evaluating the addition of nivolumab to standard first-line chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: The ETOP 6-14 NICOLAS trial (2017) (2)
- The ideal couch tracking system—Requirements and evaluation of current systems (2019) (2)
- Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards (2022) (2)
- Optimal Imaging Follow-up Schedules after Stereotactic Ablative Radiotherapy for Early Non-Small-Cell Lung Cancer: Findings of an International Delphi Consensus Study (2017) (2)
- Unconscious physiological response of healthy volunteers to dynamic respiration-synchronized couch motion (2017) (2)
- Margin calculation for multiple lung metastases treated with single-isocenter SBRT. (2021) (2)
- Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer (2022) (2)
- Definition of Oligometastatic Disease from a Radiation Oncology perspective : 1 an ESTRO-ASTRO Consensus Document 2 3 (2019) (2)
- Poor Pulmonary Function is Not Associated with Increased Rates of Toxicity or Decreased Overall Survival After Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer: Results of a Multi-institutional Analysis (2010) (2)
- Nomogram for predicting overall survival after stereotactic body radiotherapy for pulmonary metastases: Development and external validation: 198PD (2016) (2)
- STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES IN LONG BONES. (2022) (2)
- Completeness of reporting oligometastatic disease characteristics in literature and influence on oligometastatic disease classification using the ESTRO/EORTC nomenclature. (2022) (2)
- Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer. (2022) (2)
- International Consensus Contouring Recommendations for Stereotactic Body Radiotherapy of Non-Spine Bone Metastases (2020) (2)
- Probing spatiotemporal fractionation on the preclinical level (2020) (2)
- SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy (2014) (2)
- [Role of stereotactic body radiation therapy for unresected pancreatic cancer]. (2018) (2)
- Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy (2021) (2)
- Distant metastasis velocity as a novel prognostic score for overall survival after disease progression following stereotactic body radiotherapy for oligometastatic disease. (2022) (2)
- Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung. (2022) (2)
- Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease? (2021) (2)
- PO-0926: Dosimetric comparison of different motion management techniques (2015) (2)
- Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium. (2023) (2)
- Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus? (2022) (2)
- Impact of image filtering and assessment of volume-confounding effects on CT radiomic features and derived survival models in non-small cell lung cancer (2021) (2)
- Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (2)
- Extrakranielle stereotaktische Bestrahlung bei Lungenrundherden (2013) (2)
- Stellenwert der stereotaktischen Radiotherapie für das nichtresezierte Pankreaskarzinom (2018) (2)
- Lokal ablative nichtchirurgische Verfahren beim nichtkleinzelligen Bronchialkarzinom (2011) (2)
- Kein Nachweis einer Ergebnisverbesserung der Salvage-Radiotherapie beim asymptomatischen biochemischen Prostatakarzinom rezidiv nach Prostatektomie durch additive Androgensuppression (2016) (2)
- [Image-guided intensity-modulated radiation therapy decreases late gastrointestinal side effects after radiation therapy for prostate cancer]. (2017) (1)
- High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation Clinical and Translational Radiation Oncology (2021) (1)
- Performance behavior of prediction filters for respiratory motion compensation in radiotherapy (2017) (1)
- TH‐AB‐304‐06: Investigation of Fractionation Issues in NTCP Modeling of Pneumonitis: An Analysis of Common NTCP Models for Hypo‐Fractionated and Standard‐Fractionated Data (2015) (1)
- A Multinational Report on Methods for Delivery of Lung Stereotactic Radiotherapy (SBRT) using Online Volumetric Image-guidance (VIGRT): Results from the Synergy Research Group (2009) (1)
- Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation (2012) (1)
- A multi-national report on methods for institutional credentialing for spine radiosurgery (2012) (1)
- 1417TiP Immunotherapy, chemotherapy and stereotactic radiotherapy to metastases, followed by definitive surgery or radiotherapy to the primary tumour, in patients with synchronous oligo-metastatic NSCLC: The ETOP CHESS trial (2020) (1)
- Radiotherapy for glioblastoma patients with poor performance status (2021) (1)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (1)
- Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer. (2022) (1)
- PV-0315 A risk assessment method including credible intervals for lymphatic metastatic spread for HNSCC (2019) (1)
- Poster ViewingAn International Radiosurgery Consortium Survey for Gynecological Stereotactic Ablative Radiation Therapy (2017) (1)
- A Multi-national Pooled Analysis of 434 Cases of Stage I Non-small Cell Lung Cancer (NSCLC) Treated with Volumetrically Image-guided Stereotactic Lung Radiotherapy: Results from the Elekta Collaborative Lung Research Group (2010) (1)
- Grundlagen der Oligometastasierung und Stellenwert der Lokaltherapie (2020) (1)
- Influence of Delineation of the Proximal and Distal Rectum as Separated Organ-at-Risks on IMRT Treatment Planning for the Prostate (2005) (1)
- Stereotactic body radiation therapy in the re-irradiation situation – a review (2013) (1)
- OC-0056: SBRT for lung metastases: detailed subgroup analysis of 700 patients diagnosed with 963 lung metastases (2015) (1)
- Intrafraction Variation of Target Position During Cone-beam CT Image-guided Stereotactic Body Radiotherapy (SBRT) for Early-stage Non-small Cell Lung Cancer: A Collaborative Analysis (2011) (1)
- Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom (2019) (1)
- Radiotherapy dose escalation in locally advanced NSCLC - The limits of conventional radiochemotherapy. (2018) (1)
- [Palliative Radiotherapy - An Important Tool in the Event Of Painful Bone Metastases]. (2021) (1)
- Paradigmenwechsel für stereotaktische Strahlentherapie bei Oligometastasierung (2019) (1)
- A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma (2022) (1)
- Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe. (2023) (1)
- PD-0740 Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare (2021) (1)
- OC-0025 COMPARISON OF A MLC AND A HEXAPOD TRACKING SYSTEM FOR ORGAN MOTION COMPENSATION DURING RADIOTHERAPY (2012) (1)
- OC-0626 Toxicity of SRT combined with targeted agents: prospective analysis of the TOaSTT database (2021) (1)
- Konsolidierende Lokaltherapie verbessert progressionsfreies Überleben von Patienten mit oligometastasiertem NSCLC (2017) (1)
- Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis. (2022) (1)
- FDG-PET Imaging for Advanced Radiotherapy Treatment of Non-Small-Cell Lung Cancer (2015) (1)
- Körperstereotaktische Bestrahlung als „Erstlinientherapie“ des oligometastasierten Nierenzellkarzinoms (2022) (1)
- An interlaced IMRT technique for elongated tumor volumes. (2009) (1)
- In Regard to Ohri et al. (2019) (1)
- Evidenz für den Einsatz moderner Bestrahlungstechniken beim nicht-kleinzelligen Bronchialkarzinom: unnötig, ungenügend, ausreichend oder zu spät? (2012) (1)
- Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells. (2012) (1)
- Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy (2019) (1)
- Optimizing a perfusion CT protocol for head and neck cancer (2017) (1)
- Bildgeführte intensitätsmodulierte Strahlentherapie vermindert die gastrointestinalen Spätfolgen nach Radiotherapie des Prostatakarzinoms (2017) (1)
- Delta-radiomics for prediction of pseudoprogression in malignant melanoma treated with immune checkpoint inhibition. (2019) (1)
- EP-1684: Mobile health technology in severely ill patients (2018) (1)
- Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival. (2019) (1)
- Treatment plan quality during online adaptive re-planning (2020) (1)
- Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis (2014) (1)
- Abskopale Effekte der lokalen Radiotherapie in Kombination mit systemischer Immuntherapie bei Patienten mit metastasierten soliden Tumoren (2015) (1)
- Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous (2019) (1)
- Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database (2021) (1)
- SBRT in eight fractions. (2017) (1)
- EP-2108: Robustness study on radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR (2018) (1)
- PV-0312 Distributed learning in radiomics to predict overall survival in head and neck cancer (2019) (1)
- OC-0592: Implementation of MR-only one-day radiosurgery workflow for non-spinal bone metastases on MR-Linac (2020) (1)
- Palliative Radiotherapie – ein wichtiges Instrument bei schmerzhaften Knochenmetastasen (2021) (1)
- TH-AB-303-01: Benchmarking Real-Time Adaptive Radiotherapy Systems: A Multi- Platform Multi-Institutional Study (2015) (1)
- [Stereotactic Body Radiotherapy for Early Stage NSCLC - What Is the Evidence?] (2017) (1)
- A Collaborative Analysis of Stereotactic Lung Radiotherapy (Lung SBRT) Outcomes for Stage I Non-small Cell Lung Cancer (NSCLC) using Daily Online Cone-beam CT Image-guided Radiotherapy (CBCT-IGRT) (2010) (1)
- Variability of Spinal Cord Definition Using MR T2 Versus CT Myelography for Spine Radiosurgery (2015) (1)
- Reduced Normal Tissue Doses Through Advanced Technology (2010) (1)
- Indikationen zur neoadjuvanten oder definitiven Radiochemotherapie beim Ösophaguskarzinom auf höchstem Evidenzniveau gesichert (2012) (1)
- EP-1910 CT image standardization is superior to larger but heterogeneous datasets for robust radiomic models (2019) (1)
- Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? (2015) (1)
- Kein Überlebensvorteil durch 5-FU-basierte adjuvante Chemotherapie (2014) (1)
- intracranial high precision radiotherapy; first phantom and clinical results (2010) (1)
- [Local consolidative therapy improves progression-free survival in patients with oligometastatic NSCLC : Results of a randomized phase II study]. (2017) (1)
- OC-0513: In-silico comparison of five automated treatment planning solutions for primary head and neck cancer (2018) (1)
- Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective (2016) (1)
- [Indications for neoadjuvant or definitive radiochemotherapy in esophageal cancer of the highest evidence quality]. (2012) (1)
- Osteopontin Plasma Levels in Head and Neck Cancer Patients During Radiotherapy (2010) (1)
- Stereotactic Body Radiotherapy (2017) (1)
- Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition (2022) (1)
- Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics (2020) (1)
- OP0150 MACHINE LEARNING APPROACHES FOR RISK MODELLING IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS USING HIGH DIMENSIONAL IMAGE ANALYSIS (2021) (1)
- Expiration Breath-Hold for SBRT in Liver and Abdominal Tumors (2019) (1)
- Postgraduate education in radiation oncology during the COVID-19 pandemic – What did we learn? (2022) (1)
- Predictive Value of Radiomics Analysis for Local Tumor Control After Radiochemotherapy in Patients With Head and Neck cancer (2016) (1)
- No Difference in Outcome Between Biopsied Versus Nonbiopsied Early Stage Medically Inoperable Non-small Cell Lung Cancer Patients Treated With Volumetric Image Guided Stereotactic Body Radiation Therapy (SBRT): Analysis of a Large Multi-institutional Database (2012) (1)
- Multimodality Imaging for Planning and Assessment in Radiation Therapy (2018) (1)
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives (2018) (0)
- PV-0044: Repeat sbrt for pulmonary oligo-metastases (2018) (0)
- Transferability of radiomic signatures from experimental to human interstitial lung disease (2022) (0)
- PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
- Erratum to: Strahlentherapie und Onkologie, Volume 186 (No. 10) Guckenberger M, Ok S, Polat B, Sweeney RA, Flentje M. Toxicity after Intensity-Modulated, Image-Guided Radiotherapy for Prostate Cancer. Strahlenther Onkol 2010;186:535–43 (DOI 10.1007/s00066-010-2144-z) (2010) (0)
- Thorax (2019) (0)
- Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue (2020) (0)
- SP-0272: The role of tumor growth models for CTV definition (2020) (0)
- SP-0375: The role of radiotherapy in current management of oligometastatic patients (2020) (0)
- Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer. (2023) (0)
- PO-1804 Local radiomics and clinical variables to predict radiation-induced pneumonitis in NSCLC patients (2021) (0)
- Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy (2021) (0)
- Durvalumab and tremelimumab plus local tumor ablation (RFA or stereotactic radiotherapy) in patients with metastatic colorectal cancer with unresectable liver metastases: Results of the EORTC-1560-GITCG (ILOC) phase II study. (2023) (0)
- [In Process Citation]. (2016) (0)
- SP-0545 Clinical perspective and evidence on RT adaptation, has it improved outcome? (2019) (0)
- Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP) (2022) (0)
- POSTER DISCUSSION: 4: CLINICAL: PROSTATEPD-0137: Generation of geometrically adaptable IMAT plans for prostate cancer treatment (2013) (0)
- PO-1110 Clinical experience with a radiofrequency system for setup and motion monitoring of prostate radiotherapy (2015) (0)
- P05.29 Improvement of stereotactic radiosurgery plan quality with multiple non-coplanar VMAT beams (2018) (0)
- IGRT IN RADIOTHERAPY: A PRACTICAL UPDATE ON TECHNOLOGIES (2009) (0)
- P-198STEREOTACTIC BODY RADIATION THERAPY AS SALVAGE THERAPY FOR OLIGOMETASTATIC PLEURAL MESOTHELIOMA AFTER CURATIVE INTENT MULTI-MODAL THERAPY (2017) (0)
- PH-0435 ADAM17-dependent paracrine and intercellular communication in response to irradiation (2021) (0)
- OC-0362 What to expect from MR-guided beam gating: Residual motion, efficiency and dose reconstruction (2021) (0)
- Systemischer Effekt einer lokalen Strahlentherapie: erste klinische Evidenz (2021) (0)
- OC-0275 Safety and efficacy of concurrent SRT and targeted- or immunotherapy for melanoma brain metastases (2019) (0)
- Organ preservation by induction chemotherapy and CT-based 3D radiotherapy in patients with advanced laryn geal and hypopharyngeal carcinomas (2007) (0)
- [Palliative radiotherapy - alleviating symptoms and improving quality of life]. (2016) (0)
- PO-0653: Surgical interventions after previous SBRT of the spine - increased risk for complications? (2016) (0)
- OC-0453: Efficacy and safety of stereotactic radiotherapy combined with TKIs for metastatic lesions. (2020) (0)
- PO-1829 Development and optimization of a modulated arc technique for total body irradiation radiotherapy (2021) (0)
- MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS (2019) (0)
- Spinal Radiosurgery after Radiation Therapy XRT or Radiosurgery (2014) (0)
- Results of the Planning Comparison Study SBRT of NSCLC (2015) (0)
- 403 INVITED Role of Stereotactic Radiotherapy (2011) (0)
- EP-1188: Repeat Radiosurgery for new brain metastases allows avoidance of whole-brain radiation therapy (2018) (0)
- Poster ViewingMinimizing Immunosuppressive Effects of Photon and Proton Radiation Therapy on Circulating Lymphocytes (2017) (0)
- Extra-cranial SBRT in patients with oligometastatic disease: a dose-escalation study (2016) (0)
- 549 speaker THE CURRENT STATUS OF STEREOTACTIC BODY RADIOTHERAPY (2011) (0)
- Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue (2020) (0)
- Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: An International Survey of Practice Patterns (2019) (0)
- EP-2001: A Bayesian network model for personalized elective CTV definition in head and neck cancer (2018) (0)
- SP-0385: Focus on lung cancer: What a radiotherapy department should offer their patients (2017) (0)
- Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline (2023) (0)
- SAT0569 “IMAGES ARE MORE THAN PICTURES, THEY ARE DATA” [1] – EXPLORATION OF RADIOMICS ANALYSIS FOR SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (2020) (0)
- PV-0475: Stereotactic Body Radiation Therapy For Painful Spinal Metastases - Results Of A Phase 2 Study (2018) (0)
- PD-0050: Predictors and patterns of regional recurrence following lung SBRT: A report from the Elekta Lung Research Group (2015) (0)
- Development of an updated, standardized, patient-centered outcome set for lung cancer. (2022) (0)
- PO-1169: Influence of localisation of PSMA-positive oligo-metastases on efficacy of metastasis-directed EBRT (2020) (0)
- Beeinflussung der Strahlenfibrose unter Verwendung von Decorin und TGFbeta-Antikörpern (2005) (0)
- PO-0980: Primary tumor and lymph nodes CT radiomics to predict loco-regional control in head and neck cancer (2018) (0)
- OC-0645 Head and neck radiotherapy on the MR-Linac: a multicentre planning challenge on MRIdianplatform (2021) (0)
- PO-1296: First MRI Guided Cardiac Radioablation of Sustained Ventricular Tachycardia (2020) (0)
- Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen (2022) (0)
- Stereotaxic Body Radiotherapy for Stage I NSCLC (2015) (0)
- PO-1527 Single-institution analysis of cancer patients treated with multiple courses of repeat radiotherapy (2021) (0)
- P04.27 Texture feature analysis to predict overall survival in recurrent glioblastoma treated in the DIRECTOR trial (2017) (0)
- Thorax : Lungs and Esophagus (2019) (0)
- Are Lung NTCP Models Different In Hypofractionated And Standard Fractionated Radiotherapy (2014) (0)
- SP-0482 SGRT - A hype or the new standard of practice? (2021) (0)
- PO-1571: Radiomics for prediction of metastatic melanoma patient survival after immunotherapy (2020) (0)
- PO-0845: Histopathological findings after irradiation and re-irradiation of spinal bone metastases with SBRT (2018) (0)
- EP-1253: Interobserver variability in the target delineation of hepatocellular carcinoma (2017) (0)
- 48 Stereotactic Body Radiotherapy for Non-Spine Bone Metastases: An International Survey of Practice Patterns (2019) (0)
- EP-1261: Impact of sarcopenia on adverse effects in trimodality therapy for esophageal carcinoma (2016) (0)
- Real-time Couch Tracking for Prostate Cancer: Toward Submillimeter Accuracy (2010) (0)
- Survival outcome of non-small cell lung cancer (NSCLC) patients: Comparing results between the database of the Comprehensive Cancer Center Zürich (CCCZ) and the Epidemiological Cancer Registry Zurich and Zug (KKR) (2019) (0)
- Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in locally advanced non-small cell lung cancer: a pooled analysis of individual patient data from three randomized trials. (2021) (0)
- Long-term cancer survivors treated with multiple courses of repeat radiation therapy (2021) (0)
- Repeat stereotactic body radiotherapy for oligometastatic disease. (2023) (0)
- PO-1409 Imaging and blood biomarkers in metastatic melanoma patients treated with immunotherapy. (2021) (0)
- PD-0741 Application of the ESTRO/EORTC oligometastatic disease classification system to current evidence (2021) (0)
- SU-F-R-51: Radiomics in CT Perfusion Maps of Head and Neck Cancer. (2016) (0)
- SP-0213: Peripheral lesions: Too much dose? (2014) (0)
- Investigating the Reproducibility of Motion for Lung Tumours Treated with Stereotactic Body Radiotherapy (2009) (0)
- PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml. (2023) (0)
- Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort. (2016) (0)
- OC-0045 GEOMETRIC AND DOSIMETRIC ACCURACY OF FRAME-LESS IMAGE-GUIDED RADIOSURGERY IN CLINICAL PRACTICE (2012) (0)
- EP-1414: Toxicity of concurrent stereotactic radiotherapy and targeted or immunotherapy: a systematic review (2017) (0)
- Skull Base Tumors (2015) (0)
- Value of Patient Immobilization in External Beam Radiotherapy for Prostate Cancer (2014) (0)
- PO-1015 Prospective evaluation of anatomical changes of salivary glands during MRI-guided ART for HNC (2021) (0)
- Comparison of MR Preprocessing Strategies and Sequences for Radiomics-Based MGMT Prediction (2021) (0)
- PO-0861 Analysis of nodal and prostatic bed RT in oligorecurrent PC patients treated with PSMA-PETguided RT (2019) (0)
- PO-1803 Voxel-wise quantification of anatomical tumor lung location is associated with overall survival (2021) (0)
- Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (0)
- OC-0135: Can we select stage I NSCLC patients at high risk for early death prior to SBRT treatment? (2016) (0)
- OC-0163 Risk classification for PSA relapse after PSMAPET-guided RT for oligorecurrent prostate cancer (2019) (0)
- Hypofractionated radiotherapy for prostate cancer (2014) (0)
- CT image standardization is superior to larger but heterogeneous data for robust radiomic models. (2019) (0)
- Radiation Therapy in Non-small-Cell Lung Cancer (2019) (0)
- Kombination zielgerichteter Systemtherapie und zielgerichteter Radiotherapie (2015) (0)
- PO-1514: Non-coplanar trajectory VMAT for treatment of spinal metastatic tumors (2020) (0)
- FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer (2022) (0)
- Stereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations. (2023) (0)
- MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT (2017) (0)
- PD-0742 Prognostic Value of The ESTRO EORTC Classification System of Oligometastatic Disease (2021) (0)
- SC03.01 Advances in Stereotactic Body Radiotherapy (2017) (0)
- Authors' Response to Letter to the Editor "Comments on 'Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study'". (2020) (0)
- PO-0864: A planning study investigating different planning techniques for SBRT of NSCLC (2016) (0)
- Clinical and Technical Factors For Stereotactic Body Radiotherapy For Gynecological Cancer - Results from An International Radiosurgery Consortium Survey (2017) (0)
- Clinical and Technical Factors For Stereotactic Body Radiotherapy For Gynecological Cancer - Results from An International Radiosurgery Consortium Survey (2017) (0)
- Risk Factors for spinal Compression Fractures after stereotactic Irradiation of Patients with Spinal Metastases - Results of a Phase 2 Study (2019) (0)
- X-change symposium: status and future of modern radiation oncology—from technology to biology (2021) (0)
- Chance im Konzept des «Cancer as chronic disease» (2017) (0)
- A Snapshot of the Practice of Stereotactic Body Radiation Therapy From 30 Centers in 6 Countries (2014) (0)
- PC08.05 Debate #2: Keep Calm and Beam On: Thoracic Radiation Obviates the Need for Surgery (2018) (0)
- Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy (2021) (0)
- [Stereotactic body radiotherapy compared to modern surgery for treatment of early stage non-small-cell lung cancer]. (2022) (0)
- FIRE-9 – PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer (2022) (0)
- EP-1863: Radiomics in the CT perfusion maps – robustness study (2016) (0)
- OC-0593: Dosimetric analysis of local failures in skull-base chordoma/chondrosarcoma following proton therapy (2018) (0)
- THU0345 TEXTURE-BASED RADIOMICS FEATURES DISCRIMINATE DIFFERENT STAGES OF EXPERIMENTAL INTERSTITIAL LUNG DISEASE (2019) (0)
- Tumour delineation in oesophageal cancer - A comparison study of delineation in PET, CT and based on CT-visual endoscopic clip markers (2014) (0)
- Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer (2020) (0)
- PO-1113 A Set-up comparison between MV imaging and optical surface monitoring for breast cancer patients (2015) (0)
- Respiratory motion prediction filters for real time tumor tracking during radiation treatment (2015) (0)
- PO-0923 How can a limited number of proton slots be optimally used in combined proton-photon treatments? (2019) (0)
- SP-0311: Automated treatment plan generation - the Zurich experience (2016) (0)
- Aktuelle interdisziplinäre Behandlung von Knochenmetastasen (2023) (0)
- Title: Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa) Running title: Respiratory motion-management in SBRT (2020) (0)
- Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document Radiotherapy and Oncology (2020) (0)
- PO-1971 Patient experience and gating efficiency using a visual tracking system for breath hold during MRgRT (2021) (0)
- PV-0197: Comparison of manual and two automated planning solutions for stereotactic brain radiosurgery (2018) (0)
- Leukoencephalopathy after Prophylactic Whole-Brain Irradiation with or without Hippocampal Sparing: A Long-Term MRI Analysis (2019) (0)
- Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
- OC-0088 Margin calculation for multiple metastases in single-isocenter lung SBRT (2021) (0)
- How Much Lung Sparing is Achievable by Adaptive Radiotherapy in Treatment of Advanced-stage Non–small-cell Lung Cancer? (2009) (0)
- OC-0265: Effective tumor reoxygenation for combined treatment with radiotherapy (2018) (0)
- OC-0206: Dose-response modelling in SBRT for stage I NSCLC and pulmonary metastases based on a multi-institutional database (2015) (0)
- [Systemic effects of local radiotherapy: first clinical evidence]. (2021) (0)
- OC-0617: A new technique for robust VMAT treatment planning of total craniospinal irradiation (2018) (0)
- Immobilization for SBRT: A Crucial Prerequisite Toward Accurate Treatment (2019) (0)
- OC-0710: Initial clinical experience with the MR-Linac System – Treatment workflow management (2020) (0)
- [Local radiotherapy for patients with newly diagnosed, metastatic prostate cancer]. (2019) (0)
- [Which patients with localized prostate cancer benefit from which local procedure and what does "benefit" mean in prostate cancer?] (2018) (0)
- Radiosurgery as Primary Treatment for Vertebral Metastases: Results From an International Multicenter Database (2013) (0)
- OC-0424: SBRT for Primary Liver Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis (2017) (0)
- PO-0818: Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer (2020) (0)
- Efficacy and Safety of Metastasis Directed Stereotactic Radiotherapy in NSCLC Patients Progressing Under Targeted- or Immunotherapy. (2020) (0)
- Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases (2023) (0)
- EP-1563 PSMA-ligand based radiotherapy for lymph node relapsed prostate cancer after radical prostatectomy (2019) (0)
- Variability in spine radiosurgery treatment planning – results of an international multi-institutional study (2016) (0)
- Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial (2012) (0)
- Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis (2021) (0)
- OC-0305: Validation of Dynamic Treatment-Couch Tracking for Prostate SBRT (2017) (0)
- Electronic Poster: RTT track: Image guided radiotherapy and verification protocolsEP-1842: Comparison between infrared marker and surface imaging for DIBH of left-sided breast treatments (2017) (0)
- PO-0879 Mobile health for monitoring of health status in palliative care patients: a feasibility study (2019) (0)
- 143: The management of patients with extensive-stage small-cell lung cancer: A European survey of practice (2017) (0)
- Körperstereotaxie beim NSCLC im Stadium I (2014) (0)
- MA06.06 Intracavitary Cisplatin-Fibrin followed by Irradiation after Lung Sparing Surgery in a Rat Model of Malignant Mesothelioma (2021) (0)
- [Durvalumab after radiochemotherapy for locally advanced unresectable NSCLC-a breakthrough]. (2019) (0)
- A multi-institution evaluation of deformable image registration algorithms for automatic organ delineation in adaptive head and neck radiotherapy (2012) (0)
- PO-1928: Initial clinical experience with the MR-Linac System - Patient perspective (2020) (0)
- Corrigendum to “Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study” [Phys. Imaging Radiat. Oncol. 22 (2022) 131–136] (2022) (0)
- 21st Annual SASRO Meeting (2017) (0)
- First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments (2020) (0)
- PO-1020 Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (0)
- OC-0526: Can surface guided radiation therapy be used to setup DIBH breast cancer patients to reduce Imaging? (2018) (0)
- ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
- OC-0125: Relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 trial (2017) (0)
- PO-0907: TCP modeling in a large cohort of NSCLC patients inclusive of geometric uncertainties (2015) (0)
- Risk for surgical complications after previous stereotactic body radiotherapy of the spine (2017) (0)
- MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL (2020) (0)
- EP-1229 Repeated intracranial radiotherapy/SRTAnalysis of efficacy and safety including EQD2 sum plans (2019) (0)
- SP-0343: SBRT for oligometastatic disease: For the motion (2015) (0)
- EP-1365 SBRT as salvage therapy for oligometastatic pleural mesothelioma after initial curative therapy (2019) (0)
- Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. (2023) (0)
- Mobile health technology in severely ill patients (2018) (0)
- - 1-Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy ; first phantom and clinical results (2010) (0)
- Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (2022) (0)
- Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (0)
- PO-1053 cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer (2022) (0)
- 431P Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16 (2022) (0)
- PO-1648 Cell kill based treatment planning for polymetastatic patients with high tumor burden (2022) (0)
- Radiotherapy Versus Chemoradiation in Elderly Head-and-Neck Squamous Cell Carcinoma Patients – A Retrospective International Multicenter Study (2022) (0)
- Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug. (2020) (0)
- PO-1766 Deep learning classifier for MGMT promoter methylation status in glioblastoma cancer (2022) (0)
- Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study (2018) (0)
- PD-0077 Systemic Therapy-Free Survival after Stereotactic Body Radiotherapy for Oligorecurrent Disease (2022) (0)
- OC-0601 Incidence and outcomes of oligometastatic esophagogastric cancer: A multicenter cohort study (2022) (0)
- The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases (2019) (0)
- The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases (2018) (0)
- Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (0)
- OC-0069: Influence of PET radiomics implementation on reproducibility of tumor control prognostic models (2017) (0)
- Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial (2022) (0)
- SP-0412: Does the prescription isodose matter? (2016) (0)
- 115P Salvage surgery in patients with locally advanced or metastatic non-small cell lung cancer (2023) (0)
- SBRT for centrally localized NSCLC – What is too central? (2016) (0)
- EP-1386: Mobile health technologies for severely-ill and palliative care patients (2017) (0)
- Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy (2020) (0)
- PO-1563: New voxel-based approach to study the relation of tumor location and survival in NSCLC (SAKK-16/00) (2020) (0)
- Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer (2021) (0)
- Multimodal treatment in operable stage III non-small cell lung cancer using the new TNM staging classification version 8: Long term results of a pooled analysis of three SAKK trials. (2018) (0)
- EP08.03-006 Survival After Radical Treatment of Oligometastatic Non-small Cell Lung Cancer: A Multicenter Analysis (2022) (0)
- Stereotactic body radiotherapy for central lung tumours: Author reply. (2015) (0)
- Re-irradiation With Stereotactic Radiosurgery Treatment for Spinal Metastases: Results From an International Multicenter Database (2013) (0)
- PO-1063 Quality-of-life and perceptions in cancer patients treated with multiple courses of radiotherapy (2022) (0)
- Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine (2022) (0)
- PO-0981: First experiences with combined EBRT and HDR-brachytherapy boost using Co-60 in patients with prostate cancer (2013) (0)
- SP-0530 Against the motion - Photons against Protons (2022) (0)
- OC-0139: SBRT for stage I NSCLC: patterns-of-care and outcome analysis in Germany and Austria between 1998 and 2011 (2013) (0)
- PD-0083 Benefit of replanning in MR-guided online adaptive radiation therapy in liver metastasis treatment (2022) (0)
- A Survival Prediction Tool for Cancer Patients Treated with Stereotactic Radiation Therapy (2022) (0)
- Pre-emptive or reactive? PROMPT spinal screening in metastatic castration-resistant prostate cancer. (2022) (0)
- MO-0713 Stereotactic Body Radiotherapy for Long Bone Metastases: An International Multicenter Analysis (2022) (0)
- MR-guidance in clinical reality: current treatment challenges and future perspectives (2019) (0)
- PV-0042: SBRT for peripheral lung tumors >5 cm: first results of the multicenter phase I/II VOLUMES trial (2018) (0)
- Identifying core MRI sequences for reliable automatic brain metastasis segmentation (2023) (0)
- PD-0820 Explainability of deep learning-based HPV status prediction in oropharyngeal cancer (2022) (0)
- Correction to: Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer (2018) (0)
- PD-0153 Comparison of methods for T1-w brain MRI intensity normalization for quantitative MRI analysis (2022) (0)
- OC-0041 Gating has small impact on dose to OARs and PTV coverage in MR-guided daily ART of prostate cancer (2022) (0)
- MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) (2022) (0)
- OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity (2022) (0)
- Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience (2021) (0)
- PO-1157 Comprehensive comparison of prognostic scores for patients with newly diagnosed brain metastases (2022) (0)
- OC-0934 Outcomes of the EORTC 22922/10925 randomised trial according to the technique for nodal irradiation (2022) (0)
- PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial (2022) (0)
- Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial (2017) (0)
- OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis (2022) (0)
- Körperstereotaxie und Lobektomie im randomisierten Vergleich beim NSCLC Stadium I – endlich Level-I-Evidenz? (2015) (0)
- Oligometastasiertes nichtkleinzelliges Lungenkarzinom: lokaltherapeutische Optionen zur Behandlung von Lungen- und Nebennierenmetastasen (2020) (0)
- Wer ist ... Matthias Guckenberger? (2012) (0)
- Konzepte beim oligometastasierten Lungenkarzinom (2022) (0)
- Stereotaktische Bestrahlung: Lokale Tumorkontrolle enorm verbessert (2014) (0)
- Präoperative Kurzzeitradiotherapie kombiniert mit volldosierter Langzeitchemotherapie beim lokal fortgeschrittenen Rektumkarzinom (2015) (0)
- SMILE: Stereotaktische MRT-geführte Radiotherapie von lokal begrenzten Prostatakarzinomen (2022) (0)
- MASPAC: SBRT zur Schmerzkontrolle beim Pankreaskarzinom (2022) (0)
- Stellenwert der 5-FU-basierten adjuvanten Chemotherapie nach präoperativer Radiochemotherapie beim lokal fortgeschrittenen Rektumkarzinom (2014) (0)
- Bildgeführte Strahlentherapie (2011) (0)
- Wer profitiert von welchem lokalen Vorgehen? (2018) (0)
- Postoperative Bestrahlung beim Prostatakarzinom (2016) (0)
- Nichtinvasive Therapie des nicht kleinzelligen Bronchialkarzinoms im frühen Stadium mittels Hochpräzisions-Strahlentherapie – eine zukünftige Option nicht nur für inoperable Patienten? (2007) (0)
- Einfluss der CT-Simulation auf das Überleben (2012) (0)
- Versorgungsforschung in der Radioonkologie am Beispiel der Körperstereotaxie (2017) (0)
- Körperstereotaxie beim NSCLC im Stadium I (2013) (0)
- Moderne Methoden zur Schonung von Normalgewebe in der Strahlentherapie (2011) (0)
- Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie zur Behandlung des NSCLC im Stadium I (2022) (0)
- Gesamtüberleben bei Ösophaguskarzinom verlängert sich durch Radiochemotherapie (2013) (0)
- CME-Antworten zu den Fragen zu «Palliative Strahlentherapie» aus Praxis Nr. 5 (2016) (0)
- [Stereotactic body radiotherapy as "first-line treatment" for oligometastatic renal cell cancer]. (2022) (0)
- Prädiktiver Einfluss unterschiedlicher histologischer Subtypen auf die lokale Kontrolle nach stereotaktischer Bestrahlung (SBRT) von Lungenmetastasen bei Patienten mit nicht-kleinzelligem Bronchialkarzinom (NSCLC) im oligometastasierten Stadium (2018) (0)
- Durvalumab nach Radiochemotherapie beim lokal fortgeschrittenen inoperablen NSCLC – ein Sprung nach vorn (2019) (0)
- “HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer (2017) (0)
- Herausforderungen und Chancen in der radioonkologischen Behandlung von Patienten im Alter (2015) (0)
- Oligoprogression (2020) (0)
- Durvalumab nach Radiochemotherapie (2020) (0)
- Radiotherapie: Herausforderungen und Möglichkeiten bei älteren Patienten (2016) (0)
- Replik zu «Eine Professur für Palliativmedizin in der Radio-Onkologie?» (2018) (0)
- Lokale Tumortherapie (2020) (0)
- Wirksamkeit und Verträglichkeit der stereotaktischen Radiotherapie für primäre Lebertumoren in der klinischen Routineanwendung – Eine Patterns-of-Care und ErgebnisAnalyse (2017) (0)
- Tumor-adaptierte Radiotherapie bei älteren Patienten (2018) (0)
- Multimodale Therapie des Rektumkarzinoms: müssen alle Patienten operiert werden? (2016) (0)
- Extrakranielle Stereotaxie von Leber- und Pankreas Tumoren (2015) (0)
- SP-0644: How to become a department head - Clinical perspective (2020) (0)
- PV-0205: Optimization of combined proton-photon treatments (2018) (0)
- SP-0349 Manageable or oligometastatic disease: Evolution of terminology in radiation oncology (2021) (0)
- EP-1550: Radiotherapy of PSMA-positive oligometastatic recurrent prostate cancer: a single-center experience (2018) (0)
- PH-0125: Intra-fractional stability of MR-guided online adaptive SBRT for prostate cancer (2020) (0)
- Adherence to contouring and treatment planning requirements within a multicentric trial -results of the quality assurance of the SAKK 09/10 trial (2022) (0)
- [Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?]. (2015) (0)
- PV-0200: Benchmark Case results from the EORTC Lungtech trial of SBRT for patients with centrally NSCLC (2018) (0)
- PD-0429: CT radiomics differentiates levels of radiocurability in tumor subvolumes in head and neck cancer (2020) (0)
- OC-0166 Cumulative metastases volume, not number of brain metastases predicts survival in melanoma patients (2019) (0)
- SP-0328: Report on the ESTRO task group on Quality management in radiation therapy (2015) (0)
- A Multi-national Report on Methods of Image-guided Stereotactic Body Radiotherapy and Radiosurgery for Vertebral Metastases (2011) (0)
- Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer (2018) (0)
- PD-0734 Validating Brain Metastases Velocity for survival prediction in patients treated with radiosurgery (2021) (0)
- Advances in Radiation Therapy Preface (2018) (0)
- Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic (2022) (0)
- Patterns of care and outcome analysis of SBRT for colorectal lung and liver metastases in 388 patients with 500 metastases: an analysis of the DEGRO working group Stereotactic Radiotherapy (2017) (0)
- Körperstereotaktische Bestrahlung im Vergleich zu moderner Chirurgie (2022) (0)
- Principles of Image-Guided Hypofractionated Radiotherapy of Spine Metastases (2016) (0)
- [No evidence for improved outcome with salvage radiotherapy for asymptomatic biochemical prostate cancer recurrence after prostatectomy by additive androgen suppression]. (2017) (0)
- EP-1697: Does contrast agent influence the prognostic accuracy of CT radiomics based outcome modelling? (2017) (0)
- Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial). (2023) (0)
- PV-0043: Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases (2018) (0)
- Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer (2017) (0)
- 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy at low PSA values ≤ 0.5 ng/ml (2019) (0)
- EP-1575: Automated VMAT planning for whole brain irradiation with hippocampus sparing (2017) (0)
- OC-0057 Probing spatiotemporal fractionation on the preclinical level (2019) (0)
- PD-0872 Second In-field course of stereotactic body radiotherapy for thoracic tumors: a multicentre analysis (2021) (0)
- Gene expression inhibition of N-Myc downregulated gene 1 (NDRG1) monitoring and facilitation via transfectional transfer of NDRG1-siRNA constructs into- in vitro-cultured human glioblastoma cells (2011) (0)
- PET Radiomics Model Based on Multi-Centre Imaging Data of SAKK 16/00 to Predict Event-Free Survival in Locally Advanced Non-Small Cell Lung Cancer (2019) (0)
- 95 oral ADAPTATION OF RADIOTHERAPY TO A SHRINKING MACROSCOPIC TUMOR IN ADVANCED STAGE NSCLC DOES NOT UNDERDOSE THE MICROSCOPIC DISEASE AND HAS THE POTENTIAL TO INCREASE TUMOR CONTROL PROBABILITY (2011) (0)
- PO-0996: Accuracy of an optical surface monitoring device to reduce daily imaging of breast cancer patients (2017) (0)
- Lokale Radiotherapie beim mPC? (2019) (0)
- PO-1514 Prospective assessment of employees stress during the COVID-19 pandemic (2021) (0)
- Implementing Volumetric Modulated Arc Therapy (VMAT): Initial Dosimetric Results for Retrospective Patient Study (2009) (0)
- Stereotactic Body Radiotherapy (SBRT) With Biologically Equivalent Dose > 150 Gy is Associated With Improved Local Control in Patients With Squamous but not Non-Squamous Cell Carcinoma of the Lung: A Multi-Institutional Analysis. (2021) (0)
- P05.02 International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC) (2021) (0)
- EP-1748: An experimental comparison of advanced respiratory motion management techniques (2016) (0)
- PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ⩽ 0.5 NG/ML (2019) (0)
- PV-103 Linking ACROP guidelines to ICRU91: a multicentre study in lung SBRT on prescription and reporting (2019) (0)
- P2.05-044 Influence of Technological Advances and Institutional Experience on Outcome of Stereotactic Body Radiotherapy for Lung Metastases: Topic: RT Techniques (2017) (0)
- SP-0438 Precision medicine – an opportunity for medical physics and radiation oncology (2019) (0)
- EP-1486: Feasibility study of using a radiofrequency tracking system for intra-fractional monitoring during radiosurgery (2015) (0)
- Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (2018) (0)
- Unconscious physiological response of healthy volunteers to dynamic respiration-synchronized couch motion (2017) (0)
- Single Fraction Urethra-Sparing Prostate Cancer SBRT: Phase I Results of a Multicenter, Single Arm, Phase I/II Trial (2019) (0)
- OC-0523: SBRT for oligo-metastatic liver disease–effect of chemotherapy and histology on local tumor control (2017) (0)
- PO-1542 Influence of abdominal air cavities on the dose distribution of daily-adapted plans (2021) (0)
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy (2020) (0)
- PO-1784: Quality Assurance for the adaptive workflow on an MRI Linac (2020) (0)
- Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (2020) (0)
- Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease (2022) (0)
- Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy (2018) (0)
- OC-0166: Dose of stereotactic radiotherapy, local control and overall survival in cholangiocarcinoma (2018) (0)
- Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma (2021) (0)
- Evaluation of an automated knowledge based treatment planning system for head and neck (2015) (0)
- International Collaborative Propensity-Based Matched Pair Analysis of Operable Early Stage Lung Ancer Patients Treated with Stereotactic Body Radiation Therapy Compared to Resection: Differences in Recurrence and Survival with Prolonged Follow-Up (2017) (0)
- PART ONE OPTIMIZATION OF SBRT IN EARLY STAGE NSCLC (0)
- EP-2113: Clinical implementation of an optical surface monitoring system(OSMS®, Varian) in breast irradiation (2016) (0)
- INFLUENCE OFCONTINUOUS TABLEMOTIONONPATIENTBREATHINGPATTERNS (2010) (0)
- EP-1807: Imaging hypoxia with the PET-tracer F-18-fluoromisonidazole (F-MISO) First experience (2014) (0)
- IBS12.01 Questions to Be Addressed (2019) (0)
- OA12.01 PCI for Radically Treated Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Individual Patient Data of Randomized Trials (2019) (0)
- Oligorecurrent nodal prostate cancer: radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial. (2022) (0)
- Correspondence on Rajyaguru et al. (2018) (0)
- 76P Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR (2018) (0)
- SP-0054: Management of lung metastases: Stereotactic body radiotherapy as a non-invasive option (2013) (0)
- OC-0059 Stereotactic radiotherapy for oligoprogressive NSCLC: clinical scenarios affecting survival (2019) (0)
- Welche Patienten mit lokalisiertem Prostatakarzinom profitieren von welchem lokalen Vorgehen und was bedeutet „profitieren“ beim Prostatakarzinom? (2018) (0)
- EORTC recommendations radiotherapy lung cancer 2017 1 European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer (2017) (0)
- PH-0050 Detailed analysis of lymphatic progression patterns for oropharyngeal squamous cell carcinoma (2021) (0)
- EP-1522 Radiotherapy with or without antihormonal therapy for PSMA-positive oligorecurrent prostate cancer (2019) (0)
- EP-1503: Rigid and non-rigid registration dose propagation for brachytherapy treatment combined with radiotherapy (2015) (0)
- EP-1366 Repeated thoracic high-dose radiotherapy-Analysis of efficacy and safety including EQD sum plans (2019) (0)
- Radiographic Changes After Lung Stereotactic Ablative Radiation Therapy (SABR) - Can We Distinguish Fibrosis From Recurrence? A Systematic Review of the Literature (2012) (0)
- Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy (2023) (0)
- OC-0621: Comparison of perfusion CT parameters and [18F]-FDG uptake in head and neck cancer patients (2015) (0)
- SP-0654: What is the limit of hypofractionation? (2018) (0)
- PO-1211: Stereotactic radiotherapy combined with immune- or targeted therapy for renal cell cancer patients. (2020) (0)
- OP-JNCI210114 1360..1368 (2021) (0)
- HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours (2018) (0)
- PO-0866: Interactive FALCON workshops reduce variability in contouring treatment volumes for spine SBRT (2018) (0)
- Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy (2020) (0)
- Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer. (2023) (0)
- A Set-up comparison between MV imaging and optical surface monitoring for breast cancer patients (2010) (0)
- Contouring Quality and Adherence to EORTC-based Protocol Guidelines in the Randomized Phase III SAKK 09/10 Trial for Postoperative Prostate Cancer Radiotherapy: Implications for Treatment Quality and Future Clinical Trials (2020) (0)
- OC-0531 Can SGRT be used with open masks to set-up HNC patients and reduce intrafractional motion? (2019) (0)
- Current status and recent advances in resection cavity irradiation of brain metastases (2021) (0)
- Stereotactic Irradiation of the Pancreas: Case Study of a Patient With Persistent Pancreatic Fistula. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Matthias Guckenberger?
Matthias Guckenberger is affiliated with the following schools:
